Background and aims: Magnesium sulfate (MgSO 4 ) is widely used as tocolytic agent and for the prophylaxis of seizures in pre-eclampsia. Antenatal exposure to MgSO 4 has been associated with a higher risk of patent DA in preterm infants. MgSO 4 is a vasodilator and thus may exert a direct relaxant effect in the DA. Here we aimed to investigate the possible vasoactive effects of MgSO 4 in the chicken DA.
Results: MgSO 4 (2.4-7.2 mM) elicited a concentration-dependent relaxation (mean maximal relaxation: 56.7%, SD 41.8; EC 50 : 2.9 mM, SD 0.3) of O 2 -induced active tone in E19 DA rings. MgSO 4 also relaxed NE-contracted (with similar efficacy but lower potency than O 2 -contracted) and KCl-contracted (with lower efficacy and potency) E19 DA rings. MgSO 4 -induced relaxation of KCl-contracted DA rings was not significantly different between E15 and E19. Endothelium removal or the presence of the NO synthase inhibitor L-NAME, the soluble guanylate cyclase inhibitor ODQ, the cyclooxygenase inhibitor indomethacin, or the sarcoplasmic reticulum Ca 2+ -ATPase inhibitor thapsigargin did not significantly modify MgSO 4 -induced relaxation. The relaxant effect of MgSO 4 was reversed by increasing the extracellular Ca 2+ concentration.
Conclusions:
MgSO 4 , at clinically relevant concentrations, induces endothelium-independent relaxation of chicken DA. This relaxant effect may be due to inhibition of Ca 2+ entry from extracellular space.
